1. Home
  2. ARQ vs GNFT Comparison

ARQ vs GNFT Comparison

Compare ARQ & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQ
  • GNFT
  • Stock Information
  • Founded
  • ARQ 1996
  • GNFT 1999
  • Country
  • ARQ United States
  • GNFT France
  • Employees
  • ARQ N/A
  • GNFT N/A
  • Industry
  • ARQ
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ARQ
  • GNFT Health Care
  • Exchange
  • ARQ NYSE
  • GNFT Nasdaq
  • Market Cap
  • ARQ 249.0M
  • GNFT 249.0M
  • IPO Year
  • ARQ N/A
  • GNFT 2019
  • Fundamental
  • Price
  • ARQ $5.34
  • GNFT $5.91
  • Analyst Decision
  • ARQ
  • GNFT Strong Buy
  • Analyst Count
  • ARQ 0
  • GNFT 1
  • Target Price
  • ARQ N/A
  • GNFT $13.00
  • AVG Volume (30 Days)
  • ARQ 377.1K
  • GNFT 28.4K
  • Earning Date
  • ARQ 08-12-2024
  • GNFT 09-19-2024
  • Dividend Yield
  • ARQ N/A
  • GNFT N/A
  • EPS Growth
  • ARQ N/A
  • GNFT N/A
  • EPS
  • ARQ N/A
  • GNFT 0.47
  • Revenue
  • ARQ $105,078,000.00
  • GNFT $86,225,222.00
  • Revenue This Year
  • ARQ $4.58
  • GNFT $155.44
  • Revenue Next Year
  • ARQ $40.31
  • GNFT N/A
  • P/E Ratio
  • ARQ N/A
  • GNFT $12.48
  • Revenue Growth
  • ARQ 12.87
  • GNFT 175.45
  • 52 Week Low
  • ARQ $1.60
  • GNFT $2.97
  • 52 Week High
  • ARQ $8.26
  • GNFT $6.13
  • Technical
  • Relative Strength Index (RSI)
  • ARQ 42.75
  • GNFT 64.88
  • Support Level
  • ARQ $5.12
  • GNFT $5.41
  • Resistance Level
  • ARQ $5.49
  • GNFT $6.13
  • Average True Range (ATR)
  • ARQ 0.30
  • GNFT 0.28
  • MACD
  • ARQ -0.01
  • GNFT 0.04
  • Stochastic Oscillator
  • ARQ 19.47
  • GNFT 79.38

About ARQ ARQ INC

Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granular Activated Carbon, and Colloidal Carbon Product among others.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: